Hikma Pharmaceuticals USA Inc.

Form 483

Cherry Hill, New Jersey, United StatesFEI 2220525Issued April 13, 2011

View FDA's Record for This Firm

Source: FDA record for this establishment. FDA publishes inspections or enforcement actions for this establishment, listed further down this page, but we have not matched this particular Form 483 to a document or an inspection date FDA has released. It stays out of the default view for that reason. To check it, open FDA's record for this establishment on FDA's Data Dashboard, listed under FEI 2220525.

Observations2

Issue DateApril 13, 2011

StatusNo Warning Letter

Related Inspections10

Establishment Details

Firm: Hikma Pharmaceuticals USA Inc.
Location: Cherry Hill, New Jersey, United States
FEI Number: 2220525
Product Type: Drugs
Issue Date: April 13, 2011
Country: United States

Inspection History, 2014 to 2026

NAI7

VAI3

NAI means No Action Indicated. VAI means Voluntary Action Indicated.

Act on This Form 483

FDA Inspection ReadinessSee how your operations would hold up to the same scrutiny.CAPA & InvestigationsScore how you would investigate and close findings like these.Talk to a SpecialistWalk through these observations with a ComplianceQuest expert.

Hikma Pharmaceuticals USA Inc. FDA Form 483, Cherry Hill, New Jersey, April 13, 2011